MCM
JNJ icon

Mainstream Capital Management’s Johnson & Johnson JNJ Stock Holding History

Mainstream Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-436
Closed -$63.1K – 194
2024
Q4 		$63.1K Buy
+436
New +$67.6K 0.04% 126

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mainstream Capital Management's JNJ Position: Q1 2025 in Review

Mainstream Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 436 shares — an estimated $63.1K sold.

Mainstream Capital Management first reported a position in JNJ in Q4 2024 and held it in 1 quarter. The position peaked at $63.1K in Q4 2024. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Mainstream Capital Management reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Mainstream Capital Management sold 436 Johnson & Johnson shares in Q1 2025, an estimated $63.1K.
  • Mainstream Capital Management first reported a position in Johnson & Johnson in Q4 2024 and held it in 1 quarter.
  • Mainstream Capital Management's Johnson & Johnson position peaked at $63.1K in Q4 2024.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Mainstream Capital Management's 13F filing for Q1 2025, filed 28 Apr 2025.